Data Collection in Lutetium Treated Prostate Cancer: Recording of Progression and Tumor Characteristics
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
This prospective study aims to collect data and blood biomarkers from patients undergoing Lu-PSMA therapy at the Erasmus MC. In doing so, it will provide real-world efficacy and safety data on the drug, gather dosimetry data and explore putative biomarkers to identify patients who most benefit from Lu-PSMA treatment.
Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: f
View:
• Participants should be at least 18 years old.
• Participants should be able to understand the written information and be able to provide informed consent.
• Participants are planned to start treatment with Lu-PSMA as a part of regular clinical care.
Locations
Other Locations
Netherlands
Erasmus MC
RECRUITING
Rotterdam
Contact Information
Primary
Stijn Koolen, PhD
s.koolen@erasmusmc.nl
+31638740656
Time Frame
Start Date: 2024-02-20
Estimated Completion Date: 2027-02-01
Participants
Target number of participants: 150
Related Therapeutic Areas
Sponsors
Leads: Erasmus Medical Center